Current Clinical Pharmacology

Editor-in-Chief:

Arduino A. Mangoni
Flinders University and Flinders Medical Centre
Adelaide, SA
Australia

Back

Editorial [Hot topic: Selected New Developments in Oncology (Guest Editors: Jos H. Beijnen and Jan H.M. Schellens)] promotion: free to download

Volume:5   Issue:3
Pp: 140-140
Jos H. Beijnen and Jan H.M. Schellens
DOI: 10.2174/157488410791498842

Personalized Medicine in Oncology: A Personal View with Myths and Facts

Volume:5   Issue:3
Pp: 141-147
Jos H. Beijnen and Jan H.M. Schellens
DOI: 10.2174/157488410791498789

Monoclonal Antibody Therapy in Haematological Malignancies

Volume:5   Issue:3
Pp: 148-159
Martine E.D. Chamuleau, Arjan A. van de Loosdrecht and Peter C. Huijgens
DOI: 10.2174/157488410791498752

Monoclonal Antibodies in Solid Tumours

Volume:5   Issue:3
Pp: 160-165
Ben Markman and Josep Tabernero
DOI: 10.2174/157488410791498833

Molecular Targeted Therapy in Prevalent Tumors: Learning from the Past and Future Perspectives

Volume:5   Issue:3
Pp: 166-177
Otto Metzger-Filho, Camilo Moulin and Ahmad Awada
DOI: 10.2174/157488410791498716

Vascular Disrupting Agents (VDAs) in Anticancer Therapy

Volume:5   Issue:3
Pp: 178-185
Laura G.M. Daenen, Jeanine M.L. Roodhart, Yuval Shaked and Emile E. Voest
DOI: 10.2174/157488410791498815

Inducing Synthetic Lethality using PARP Inhibitors

Volume:5   Issue:3
Pp: 192-195
David S. Boss, Jos H. Beijnen and Jan H.M. Schellens
DOI: 10.2174/157488410791498798

Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review

Volume:5   Issue:3
Pp: 209-217
Ken-ichi Fujita and Alex Sparreboom
DOI: 10.2174/157488410791498806

DNA Vaccination in Oncology: Current Status, Opportunities and Perspectives

Volume:5   Issue:3
Pp: 218-225
Joost H. van den Berg, Koen Oosterhuis, Jos H. Beijnen, Bastiaan Nuijen and John B.A.G. Haanen
DOI: 10.2174/157488410791498734

Scheduling of Taxanes: A Review

Volume:5   Issue:3
Pp: 226-231
Emma J. Woodward and Chris Twelves
DOI: 10.2174/157488410791498725